Abstract

Cell signalling governs cellular behaviour and is therefore subject to tight spatiotemporal regulation. Signalling output is modulated by specialized cell membranes and vesicles which contain unique combinations of lipids and proteins. The phosphatidylinositol 4,5‐bisphosphate (PI(4,5)P2), an important component of the plasma membrane as well as other subcellular membranes, is involved in multiple processes, including signalling. However, which enzymes control the turnover of non‐plasma membrane PI(4,5)P2, and their impact on cell signalling and function at the organismal level are unknown. Here, we identify Paladin as a vascular PI(4,5)P2 phosphatase regulating VEGFR2 endosomal signalling and angiogenesis. Paladin is localized to endosomal and Golgi compartments and interacts with vascular endothelial growth factor receptor 2 (VEGFR2) in vitro and in vivo. Loss of Paladin results in increased internalization of VEGFR2, over‐activation of extracellular regulated kinase 1/2, and hypersprouting of endothelial cells in the developing retina of mice. These findings suggest that inhibition of Paladin, or other endosomal PI(4,5)P2 phosphatases, could be exploited to modulate VEGFR2 signalling and angiogenesis, when direct and full inhibition of the receptor is undesirable.

Highlights

  • Cell signalling governs cellular behaviour and is subject to tight spatiotemporal regulation

  • Paladin is an endosomal PI(4,5)P2 phosphatase interacting with vascular endothelial growth factor receptor 2 (VEGFR2)

  • Using a radioactively labelled phosphopeptide substrate and the protein tyrosine phosphatase, T cell (TC)-protein tyrosine phosphatases (PTP), as a positive control we confirmed the data by Huang and co-workers that Paladin lacks phospho-tyrosine activity (Fig EV1D; Huang et al, 2009)

Read more

Summary

Introduction

Cell signalling governs cellular behaviour and is subject to tight spatiotemporal regulation. The receptor was degraded over time after VEGF-A stimulation when comparing PALD1 siRNA and control-treated cells (Figs 2A and EV2B).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call